Dr. Rita Numerof spoke with BioPharma Dive about drug manufacturers launching authorized generics of their own branded drugs, and the strategy behind making this unconventional move.

Holding onto customers via a lower list price is preferable, even if authorized generics essentially “cannibalize your own products before your competition does.”

Read the full story at biopharmadive.com